BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38842275)

  • 1. Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.
    Zhou W; Yang Y; Wang W; Yang C; Cao Z; Lin X; Zhang H; Xiao Y; Zhang X
    Cell Cycle; 2024 Jun; ():1-17. PubMed ID: 38842275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma.
    Bai M; Yuan M; Liao H; Chen J; Xie B; Yan D; Xi X; Xu X; Zhang Z; Feng Y
    Oncol Rep; 2015 Apr; 33(4):1745-52. PubMed ID: 25634023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 6. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
    Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
    Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1.
    Chen D; Xie S; Wu Y; Cui Y; Cai Y; Lan L; Yang H; Chen J; Chen W
    Front Oncol; 2020; 10():572672. PubMed ID: 33643896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
    Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Yang Y; Wang F; Huang H; Zhang Y; Xie H; Men T
    Onco Targets Ther; 2019; 12():1351-1358. PubMed ID: 30863101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA RNF10 inhibits tumorigenicity by targeting miR-942-5p/GOLIM4 axis in breast cancer.
    Kan B; Yan G; Shao Y; Zhang Z; Xue H
    Environ Mol Mutagen; 2022 Aug; 63(7):362-372. PubMed ID: 36054164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M; Xu Y; Yin S; Qiu F
    Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.